The Binding of Unfractionated Heparin and Low Molecular Weight Heparin to Thrombin-Activated Human Endothelial Cells
- 1 December 1999
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 96 (5) , 373-381
- https://doi.org/10.1016/s0049-3848(99)00125-5
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- Specific binding between human neutrophils and heparinBritish Journal of Haematology, 1992
- HeparinNew England Journal of Medicine, 1991
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990
- Pharmacokinetic Studies of Standard Unfractionated Heparin, and Low Molecular Weight Heparins in the RabbitSeminars in Thrombosis and Hemostasis, 1988
- Internalization and metabolism of endogenous heparin by cultured endothelial cellsBiochemical and Biophysical Research Communications, 1986
- Binding and endocytosis of heparin by human endothelial cells in cultureBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1985
- Evaluation of an amidolytic heparin assay method: Increased sensitivity by adding purified antithrombin IIIThrombosis Research, 1977
- Heparin kinetics in venous thrombosis and pulmonary embolism.Circulation, 1976
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIAJournal of Clinical Investigation, 1973